AU Patent

AU2013358897B2 — Pharmaceutical compositions

Assigned to GlaxoSmithKline LLC · Expires 2017-01-05 · 9y expired

What this patent protects

The present Invention relates to long acting pharmaceutical compositions of betulin defivatives or pharmaceutically acceptabnle salts thereof, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.

USPTO Abstract

The present Invention relates to long acting pharmaceutical compositions of betulin defivatives or pharmaceutically acceptabnle salts thereof, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013358897B2
Jurisdiction
AU
Classification
—
Expires
2017-01-05
Drug substance claim
No
Drug product claim
No
Assignee
GlaxoSmithKline LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.